Translational analysis of cerebrovascular dysfunction in aging
Translational analysis of cerebrovascular dysfunction in aging
批准号:
10320860
负责人:
Andriy Yabluchanskiy
金额:
$31.37万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-02-01 至 2023-12-31
关键词:
AffectAgeAge-YearsAgingAnimal ModelAnimalsAortaAstrocytesBiological AvailabilityBrainCell AgingCell physiologyCellsCerebrovascular CirculationCerebrovascular DisordersCerebrovascular systemCerebrumClinicalClinical ResearchCognitionCognitiveDNA DamageDataElderlyEndothelial CellsEndotheliumExcisionFunctional Magnetic Resonance ImagingFunctional disorderGaitGait abnormalityGeneticGeroscienceHealth Care CostsHormonesHumanIGFBP1 geneImpaired cognitionImpairmentIndividualInsulin-Like Growth Factor IInsulin-Like-Growth Factor I ReceptorInterventionLaser Speckle ImagingLeadMediatingModelingMolecularMotorMusNeuronsNitric OxideOxidative StressPathologyPerformancePeripheralPersonal CommunicationPharmacologyPhenotypePlasmaPlayProcessQuality of lifeReporterResearchResearch DesignRoleSignal TransductionStimulusStressTestingTimeTissuesVascular Cognitive Impairmentage groupage relatedagedaging brainbasecell typecerebral hemodynamicscognitive functioncognitive performancedisabilityendothelial dysfunctionfunctional disabilityfunctional near infrared spectroscopyhuman subjectimprovedimproved outcomein vivoknock-downmiddle agemouse modelneurovascular couplingneurovascular unitnovelnovel strategiespreventresponserestorationsenescencetranscriptomicstranslational study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Age-related vascular cognitive impairment (VCI) and gait abnormalities are the two most common causes of
disability in older adults that lead to loss of independence and severely reduce quality of life. Recent studies
have concluded that cerebromicrovascular pathologies play an important role in the manifestation of VCI and
gait abnormalities. One of the fundamental roles of the cerebrovasculature is to match cerebral blood flow (CBF)
with energetic demands of neurons through a process known as neurovascular coupling (NVC). NVC maintains
an optimal cerebral tissue microenvironment and requires microvascular dilation induced by nitric oxide (NO)
released from cerebromicrovascular endothelial cells (CMVECs) in response to neuronal/astrocytic activation.
Recent studies demonstrate that inhibition of NO-mediated NVC responses in mice results in impaired cognitive
performance and gait abnormalities. Importantly, one of the factors that regulates NVC and cognition in animal
models is the vasoprotective hormone insulin-like growth factor-1 (IGF-1) that has been shown to decrease with
age and influences many cell-types in brain. Recent findings suggest that age-related decline of circulating IGF-
1 promotes stress and DNA damage and is associated with increased expression of markers of cellular
senescence in brain and aorta. Despite recent advances, there is a critical gap in our understanding related to
specific molecular mechanisms that promote cerebromicrovascular endothelial dysfunction in aging, and
whether the age-dependent deficiency of circulating IGF-1 is associated with impairments in NVC and higher
brain functions (including cognition and gait) in humans. Our overall hypothesis is that age-associated IGF-1
deficiency promotes endothelial dysfunction and impairments in NVC by inducing endothelial cell senescence,
which contribute to cognitive impairment and gait abnormalities in older animals and humans. The following aims
are proposed: Aim 1) Assess whether dysfunction of NVC is mediated through a specific effect of IGF-1
deficiency on CMVECs and whether endothelial cell senescence contributes to this impairment. In this aim we
will use novel model ofdisruption of IGF-1 signaling specifically in endothelial cells and a novel mouse model
(p16-3MR) which allows to specifically eliminate senescent cells. Aim 2) Determine the relationship between
age, circulating IGF-1 status, endothelial function, NVC responses, cognition and gait in human subjects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational analysis of cerebrovascular dysfunction in aging
-
批准号:10077916
-
项目类别:
-
资助金额:$29.56万
-
财政年份:2019
-
负责人:Andriy Yabluchanskiy
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: